Nonmedicinal Interventions in Nonalcoholic Fatty Liver Disease
Author(s) -
Manuela G. Neuman,
Radu M. Nanau,
Lawrence B. Cohen
Publication year - 2015
Publication title -
canadian journal of gastroenterology and hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.921
H-Index - 65
eISSN - 2291-2797
pISSN - 2291-2789
DOI - 10.1155/2015/273595
Subject(s) - medicine , nonalcoholic fatty liver disease , steatosis , fibrosis , disease , fatty liver , liver disease , steatohepatitis , gastroenterology , nonalcoholic steatohepatitis , bioinformatics , biology
Unhealthy diet and lack of physical exercise are responsible for fat accumulation in the liver, which may lead to liver disease. Histologically, the severity of the disease has two stages: nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). NAFLD is defined by the presence of steatosis with no evidence of cellular injury such as hepatocyte ballooning. NASH is a distinct entity from NAFLD, and is characterized by the presence of inflammation with hepatocytes damage, with or without fibrosis. While several therapeutic strategies have been proposed to improve this condition, the present review aims to discuss nonmedicinal interventions used to reduce liver involvement or to prevent the disease altogether. The authors investigated dietary patterns and vitamin deficiencies associated with NAFLD, and their role in enhancing disease severity. Additionally, they reviewed the role of exercise and the use of interventions, such as as intragastric balloon and bariatric surgery, for improving disease progression. The authors propose monitoring disease progression or repair by following changes in cytoadipokine levels.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom